Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Losartan and magnesium sulfate administration reduce gentamicin-induced nephrotoxicity in rat model

View through CrossRef
Background: Nephrotoxicity is the most known side effect of gentamicin. In addition, renin angiotensin system (RAS) plays an important role in the pathogenesis of renal injury and nephrotoxicity. Hypomagnesaemia is other complication of gentamicin. Previous studies reported that magnesium plays an important role in cell enzymatic functions, reducing lipid peroxidation. Objectives: We investigated the role of losartan and magnesium sulfate (MgSO4 ) on gentamicin nephrotoxicity. Materials and Methods: In this study, rats randomly assigned to five groups. The first group, received saline, the second group received gentamicin 80 mg/kg/d, intraperitoneally (ip), and the third group, received a regular dose of losartan, 10 mg/kg/d + gentamicin 80 mg/kg/d. The fourth group received MgSO4 , 80 mg/kg/d + gentamicin 80 mg/kg/d. The fifth group obtained a continuous dose of gentamicin 80 mg/kg/d + losartan 10 mg/kg/d + MgSO4 80 mg/kg/d simultaneously. Nine days after administration of drugs, blood samples were collected from the heart. The level of urea, creatinine (Cr), malondialdehyde (MDA) and nitrite were measured in the animal serum and homogenized kidney tissue. Results: Gentamicin increased serum urea and Cr levels. The administration of losartan and MgSO4 lonely and combination of them, significantly reduced the levels of serum urea and Cr. Losartan alone and combination of losartan and MgSO4 compared with gentamicin, significantly decreased kidney MDA level too. Decrease of kidney nitrite level by gentamicin was compensated by the administration of losartan, MgSO4 alone or their combination. Additionally, losartan and MgSO4 alone and their combination together significantly reduced renal damage. Conclusions: The results of this study indicated that administration of losartan and MgSO4 individually and their combination decreased kidney nephrotoxicity and improved renal function. This effect is probably related to the improvement of antioxidant status and renal blood flow.
Title: Losartan and magnesium sulfate administration reduce gentamicin-induced nephrotoxicity in rat model
Description:
Background: Nephrotoxicity is the most known side effect of gentamicin.
In addition, renin angiotensin system (RAS) plays an important role in the pathogenesis of renal injury and nephrotoxicity.
Hypomagnesaemia is other complication of gentamicin.
Previous studies reported that magnesium plays an important role in cell enzymatic functions, reducing lipid peroxidation.
Objectives: We investigated the role of losartan and magnesium sulfate (MgSO4 ) on gentamicin nephrotoxicity.
Materials and Methods: In this study, rats randomly assigned to five groups.
The first group, received saline, the second group received gentamicin 80 mg/kg/d, intraperitoneally (ip), and the third group, received a regular dose of losartan, 10 mg/kg/d + gentamicin 80 mg/kg/d.
The fourth group received MgSO4 , 80 mg/kg/d + gentamicin 80 mg/kg/d.
The fifth group obtained a continuous dose of gentamicin 80 mg/kg/d + losartan 10 mg/kg/d + MgSO4 80 mg/kg/d simultaneously.
Nine days after administration of drugs, blood samples were collected from the heart.
The level of urea, creatinine (Cr), malondialdehyde (MDA) and nitrite were measured in the animal serum and homogenized kidney tissue.
Results: Gentamicin increased serum urea and Cr levels.
The administration of losartan and MgSO4 lonely and combination of them, significantly reduced the levels of serum urea and Cr.
Losartan alone and combination of losartan and MgSO4 compared with gentamicin, significantly decreased kidney MDA level too.
Decrease of kidney nitrite level by gentamicin was compensated by the administration of losartan, MgSO4 alone or their combination.
Additionally, losartan and MgSO4 alone and their combination together significantly reduced renal damage.
Conclusions: The results of this study indicated that administration of losartan and MgSO4 individually and their combination decreased kidney nephrotoxicity and improved renal function.
This effect is probably related to the improvement of antioxidant status and renal blood flow.

Related Results

Losartan Monotherapy vs Combination Regimens in IgA Nephropathy: A Systematic Review and Network Meta-analysis
Losartan Monotherapy vs Combination Regimens in IgA Nephropathy: A Systematic Review and Network Meta-analysis
Background: IgA nephropathy (IgAN) is a disorder in which Immunoglobulin A (IgA) antibodies build up, causing kidney damage. Losartan, an Angiotensin Receptor Blocker (ARB), has sh...
Runahead threads
Runahead threads
Los temas de investigación sobre multithreading han ganado mucho interés en la arquitectura de computadores con la aparición de procesadores multihilo y multinucleo. Los procesador...
Clinical Pharmacology of Gentamicin
Clinical Pharmacology of Gentamicin
Gentamicin is an important agent for the treatment of many serious gram-negative bacillary infections. Gentamicin is the aminoglycoside of first-choice because the reliable activit...
Reduced Enzymatic Antioxidant Defense Mechanism in Kidney Tissues from Gentamicin-Treated Guinea Pigs: Effects of Vitamins E and C
Reduced Enzymatic Antioxidant Defense Mechanism in Kidney Tissues from Gentamicin-Treated Guinea Pigs: Effects of Vitamins E and C
In this study, the activities of major enzymes participating in free radical metabolism (xanthine oxidase, XO; CuZn and Mn superoxide dismutases, SOD; glutathione peroxidase, GSH-P...
A systematic review and meta-analysis of candesartan and losartan in the management of essential hypertension
A systematic review and meta-analysis of candesartan and losartan in the management of essential hypertension
Background: Candesartan is a relatively novel antihypertensive agent of the angiotensin receptor blocker (ARB). Several clinical trials have compared candesartan with losartan in t...
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
1.Effect of chronic haloperidol treatment on D‐2 receptors labelled by (3H)‐spiperone in homogenates of rat corpus striatum. A. L. Gundlach, D. J. de Vries and P. M. Beart2.The eff...

Back to Top